Recent results with immune checkpoint inhibitors in advanced-stage non-small cell lung cancer

A tétel rövid nézete
dc.contributor.advisorMegyeri, Atilla
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorNajar, Diar Karim
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentDrimba, László
dc.contributor.opponentPórszász, Róbert
dc.contributor.opponentdeptKenézy Kórház Központi Aneszteziológiai és Intezív Terápiás Osztályhu_HU
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.date.accessioned2020-02-04T11:46:48Z
dc.date.available2020-02-04T11:46:48Z
dc.date.created2019-10-11
dc.description.abstractI have done my thesis about Recent results with immune checkpoint inhibitors in advanced stage non small cell lung cancer. In my thesis I discuss the application of Immun-oncotherapy as a current hot area for Cancer therapy. Drugs that target PD-1, PD-1L and CTLA-4 are currently highly investigated for the treatment of various cancers including Non-small cell lung cancer. Currently Two PD-1 Inhibitors are FDA approved for such indication and hopefully in the near future many more will become incorporated into the standard current regimen of NSCLC therapy.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.coursespecOrvosbiológia-farmakológiahu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent39hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/280310
dc.language.isoenhu_HU
dc.subjectThesishu_HU
dc.subjectImmun-oncotherapyhu_HU
dc.subjectPD-1L Inhibitorshu_HU
dc.subjectCTLA-4 Blockershu_HU
dc.subjectPharmacologyhu_HU
dc.subjectPD-1 Inhibitorshu_HU
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.titleRecent results with immune checkpoint inhibitors in advanced-stage non-small cell lung cancerhu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Medicine)